Assessment of the prognostic capacity of pretreatment, interim, and post-therapy 18F-FDG PET/CT in extranodal natural killer/T-cell lymphoma, nasal type
Authors:
- 24 March 2015
- journal article
- research article
- Published by Springer Nature in Annals of Nuclear Medicine
- Vol. 29 (5) , 442-451
Abstract
Although the prognostic value of positron emission tomography/computed tomography (PET/CT) using [18F]-fluorodeoxyglucose (18F-FDG) has been widely confirmed for diffuse large B cell lymphoma, its value for extranodal natural killer/T-cell lymphoma, nasal type (ENKTL), is still controversial. Therefore, we designed a prospective study to investigate the prognostic value of 18F-FDG PET/CT in patients with ENKTL.Keywords
This publication has 15 references indexed in Scilit:
- Prognostic value of whole-body metabolic tumour volume and total lesion glycolysis measured on 18F-FDG PET/CT in patients with extranodal NK/T-cell lymphomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2013
- Prognostic Value of Interim and Posttherapy 18F-FDG PET/CT in Patients with Mature T-Cell and Natural Killer Cell LymphomasJournal of Nuclear Medicine, 2013
- 18F-FDG PET/CT for Early Response Assessment in Diffuse Large B-Cell Lymphoma: Poor Predictive Value of International Harmonization Project InterpretationJournal of Nuclear Medicine, 2011
- Treatment of localized extranodal NK/T cell lymphoma, nasal typeInternational Journal of Hematology, 2010
- 18F-fluorodeoxyglucose–positron emission tomography before, during and after treatment in mature T/NK lymphomas: a study from the GOELAMS groupAnnals of Oncology, 2010
- Standards for PET Image Acquisition and Quantitative Data AnalysisJournal of Nuclear Medicine, 2009
- The role of FDG-PET scans in patients with lymphomaBlood, 2007
- Use of Positron Emission Tomography for Response Assessment of Lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in LymphomaJournal of Clinical Oncology, 2007
- PET and PET/CT for response evaluation in lymphoma: Current practice and developmentsLeukemia & Lymphoma, 2007
- Prognostic value of positron emission tomography in the evaluation of post‐treatment residual mass in patients with Hodgkin's disease and non‐Hodgkin's lymphomaBritish Journal of Haematology, 2001